chr22-16783834-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001386955.1(XKR3):c.1165G>T(p.Ala389Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000287 in 1,614,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001386955.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XKR3 | NM_001386955.1 | c.1165G>T | p.Ala389Ser | missense_variant | 4/4 | ENST00000684488.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XKR3 | ENST00000684488.1 | c.1165G>T | p.Ala389Ser | missense_variant | 4/4 | NM_001386955.1 | P1 | ||
XKR3 | ENST00000331428.5 | c.1165G>T | p.Ala389Ser | missense_variant | 4/4 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152144Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.000296 AC: 432AN: 1461868Hom.: 0 Cov.: 70 AF XY: 0.000309 AC XY: 225AN XY: 727232
GnomAD4 genome AF: 0.000204 AC: 31AN: 152262Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2022 | The c.1165G>T (p.A389S) alteration is located in exon 4 (coding exon 3) of the XKR3 gene. This alteration results from a G to T substitution at nucleotide position 1165, causing the alanine (A) at amino acid position 389 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at